Why Should You Attend?
CIB offers unparalleled access to the people, ideas, and technologies shaping the future of the industrial biotech. We invite you to be part of this vibrant, forward-looking community regardless of what stage of development your product is in. Here are just some of the reasons to attend:
-
Learn from industry veterans: Hear hard-won lessons and practical insights from seasoned professionals on what it takes to successfully commercialize biotech innovations — not just theories. Presentations will focus on lessons learned from companies that have scaled industrial biotechnology successfully, with discussions around technical risk, cost reduction, regulatory hurdles, and go-to-market strategy. Understand how leading companies are approaching capital efficiency, sustainability targets, feedstock selection, and product differentiation in today’s bioeconomy.
-
Stay ahead of market and technology trends: Discover the latest in technologies, emerging products, market needs, and companies shaping the future of industrial biotechnology, synthetic biology, and fermentation. Get a clear view of where industrial biotechnology markets are heading and which technologies are most likely to succeed commercially over the next decade.
-
Build valuable connections: Network with leaders across industry, academia, and investment communities — a chance to find collaborators, partners, funders, or new teammates. CIB will have both organized and loose networking time throughout the program to have priceless conversations with other attendees, whether at the breaks, reception, or poster session.
-
Increase visibility for your work or company: Present your company’s technology or research, get noticed by key players in the bioeconomy, and position yourself within an influential community driving commercialization. Submit an abstract to get your work directly in front of the most important leaders of biotech.
-
Contribute to shaping the field: Be part of discussions that influence how industrial biotech innovations are scaled from lab prototypes to commercially viable, competitive, and sustainable technologies.